Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide dinitrate after ESWL for renal stone clearance
IRCT20150317021497N9Phase 3Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nephrolithiasis comparing Isosorbide dinitrate with Placebo (2 arms). Primary endpoints: Stone free and Duration of stone excretion. Started Dec 2023; status: completed.
02
Drugs
isosorbide dinitrate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20150317021497N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150317021497N9.